\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ is\\ pending\\ treatment\\ and\\ work\\ up\\ by\\ urology\\.\ \(0\)\
\-\ sonographic\\ images\\ demonstrate\\ a\\ sessile\\ lobular\\ soft\\ tissue\\ mass\\ along\\ the\\ left\\ wall\\ of\\ the\\ bladder\\ with\\ positive\\ color\\ flow\\ with\\ doppler\\.\\ \\ no\\ hydronephrosis\\ was\\ demonstrated\\.\ \(0\)\
\-\ transitional\\ cell\\ carcinoma\\ of\\ the\\ bladder\ \(2\)\
\-\ transitional\\ cell\\ carcinoma\ \(13\)\
\-\ squamous\\ cell\\ carcinoma\ \(52\)\
\-\ benign\\ neoplasm\ \(14\)\
\-\ 77\\ year\\ old\\ white\\ female\\ with\\ history\\ of\\ increasing\\ creatinine\\.\\ \\ no\\ history\\ of\\ hematuria\\.\\ \\ past\\ medical\\ history\\ includes\\ hypertension\\ and\\ hyperlipidemia\\.\\ \\ no\\ prior\\ history\\ of\\ smoking\\.\\ \\ patient\\ had\\ no\\ history\\ of\\ occupational\\ exposure\\ to\\ chemicals\\.\ \(0\)\
\-\ most\\ common\\ malignant\\ urothelial\\ neoplasm\\ is\\ transitional\\ cell\\ carcinoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ transitional\\:\\ 0\\.40425594261697356\ \(0\)\
\-\ carcinoma\\:\\ 0\\.29894563050892786\ \(0\)\
\-\ cell\\:\\ 0\\.28589701769006953\ \(0\)\
\-\ history\\:\\ 0\\.23868097519284034\ \(0\)\
\-\ bladder\\:\\ 0\\.19391490888105636\ \(0\)\
\-\ chemicals\\:\\ 0\\.18463186242692342\ \(0\)\
\-\ neoplasm\\:\\ 0\\.17058750169397754\ \(0\)\
\-\ no\\:\\ 0\\.16252267340851492\ \(0\)\
\-\ urothelial\\:\\ 0\\.16247436954622688\ \(0\)\
\-\ sessile\\:\\ 0\\.1529394265134749\ \(0\)\
\-\ of\\:\\ 0\\.1467070143873415\ \(0\)\
\-\ occupational\\:\\ 0\\.14631844961520174\ \(0\)\
\-\ urology\\:\\ 0\\.13712222560379891\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.13712222560379891\ \(0\)\
\-\ creatinine\\:\\ 0\\.1272222175611998\ \(0\)\
\-\ lobular\\:\\ 0\\.12682755114405123\ \(0\)\
\-\ 77\\:\\ 0\\.12495432532226584\ \(0\)\
\-\ exposure\\:\\ 0\\.11874306413434302\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.11595389865201858\ \(0\)\
\-\ smoking\\:\\ 0\\.11571710290198756\ \(0\)\
\-\ color\\:\\ 0\\.11264560445250936\ \(0\)\
\-\ sonographic\\:\\ 0\\.11244185048510075\ \(0\)\
\-\ squamous\\:\\ 0\\.11244185048510075\ \(0\)\
\-\ doppler\\:\\ 0\\.11184171997068254\ \(0\)\
\-\ hematuria\\:\\ 0\\.11050223057323358\ \(0\)\
\-\ pending\\:\\ 0\\.10276421383011033\ \(0\)\
\-\ work\\:\\ 0\\.10187007361877186\ \(0\)\
\-\ increasing\\:\\ 0\\.09840443096401456\ \(0\)\
\-\ includes\\:\\ 0\\.09715840441464785\ \(0\)\
\-\ hypertension\\:\\ 0\\.09560017290344967\ \(0\)\
\-\ malignant\\:\\ 0\\.08906519616510841\ \(0\)\
\-\ benign\\:\\ 0\\.08582873142180164\ \(0\)\
\-\ along\\:\\ 0\\.08370831734405752\ \(0\)\
\-\ flow\\:\\ 0\\.08322215548242298\ \(0\)\
\-\ white\\:\\ 0\\.08243512254342078\ \(0\)\
\-\ positive\\:\\ 0\\.08233228952098523\ \(0\)\
\-\ past\\:\\ 0\\.08132967085047524\ \(0\)\
\-\ patient\\:\\ 0\\.08127662436349249\ \(0\)\
\-\ medical\\:\\ 0\\.07940749887749109\ \(0\)\
\-\ demonstrated\\:\\ 0\\.07678779009458117\ \(0\)\
\-\ wall\\:\\ 0\\.0760054428746142\ \(0\)\
\-\ the\\:\\ 0\\.07479312046662602\ \(0\)\
\-\ with\\:\\ 0\\.07339733589673979\ \(0\)\
\-\ common\\:\\ 0\\.07085808457732301\ \(0\)\
\-\ prior\\:\\ 0\\.06990690582657946\ \(0\)\
\-\ is\\:\\ 0\\.06843403394450082\ \(0\)\
\-\ soft\\:\\ 0\\.06651802000766624\ \(0\)\
\-\ tissue\\:\\ 0\\.06554329217039784\ \(0\)\
\-\ most\\:\\ 0\\.06502512321187476\ \(0\)\
\-\ demonstrate\\:\\ 0\\.06495540412845882\ \(0\)\
\-\ had\\:\\ 0\\.06225215621869845\ \(0\)\
\-\ up\\:\\ 0\\.061805546994534735\ \(0\)\
\-\ female\\:\\ 0\\.060291689828102735\ \(0\)\
\-\ treatment\\:\\ 0\\.0595178982357285\ \(0\)\
\-\ images\\:\\ 0\\.05779534686831456\ \(0\)\
\-\ by\\:\\ 0\\.053058862231184244\ \(0\)\
\-\ and\\:\\ 0\\.05163667869222303\ \(0\)\
\-\ mass\\:\\ 0\\.04772562645281576\ \(0\)\
\-\ was\\:\\ 0\\.04354454386431276\ \(0\)\
\-\ left\\:\\ 0\\.04262143944548634\ \(0\)\
\-\ year\\:\\ 0\\.03850556636208246\ \(0\)\
\-\ old\\:\\ 0\\.036978672740176334\ \(0\)\
\-\ to\\:\\ 0\\.031235986171419657\ \(0\)\
